MDxHealth Q2 2024 GAAP EPS $(0.42) Misses $(0.27) Estimate, Sales $22.159 Miss $20.214M Estimate
Portfolio Pulse from Benzinga Newsdesk
MDxHealth reported a Q2 2024 GAAP EPS of $(0.42), missing the $(0.27) estimate, and sales of $22.159 million, missing the $20.214 million estimate. This represents a significant decrease from the previous year's sales of $16.645 million.
August 21, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MDxHealth's Q2 2024 earnings report shows a significant miss on both EPS and sales estimates, indicating potential challenges in financial performance.
MDxHealth's reported EPS of $(0.42) was significantly below the expected $(0.27), and sales of $22.159 million also missed the $20.214 million estimate. This double miss suggests potential operational or market challenges, likely leading to negative investor sentiment and a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100